title: Ligand-independent dimerization of the human prolactin receptor isoforms: functional implications.
abstract: Prolactin (PRL) contributes to the growth of normal and malignant breast tissues. PRL initiates signaling by engaging the PRL receptor (PRLr), a transmembrane (TM) receptor belonging to the cytokine receptor family. The accepted view has been that PRL activates the PRLr by inducing dimerization of the receptor, but recent reports show ligand-independent dimerization of other cytokine receptors. Using coimmunoprecipitation assays, we have confirmed ligand-independent dimerization of the PRLr in T47D breast cancer and HepG2 liver carcinoma cells. In addition, mammalian cells transfected with differentially epitope-tagged isoforms of the PRLr indicated that long, intermediate, and DeltaS1 PRLrs dimerized in a ligand-independent manner. To determine the domain(s) involved in PRLr ligand-independent dimerization, we generated PRLr constructs as follows: (1) the TM-ICD, which consisted of the TM domain and the intracellular domain (ICD) but lacked the extracellular domain (ECD), and (2) the ECD-TM, which consisted of the TM domain and the ECD but lacked the ICD. These constructs dimerized in a ligand-independent manner in mammalian cells, implicating a significant role for the TM domain in this process. These truncated PRLrs were functionally inert alone or in combination in cells lacking the PRLr. However, when introduced into cells containing endogenous PRLr, the ECD-TM inhibited human PRLr signaling, whereas the TM-ICD potentiated human PRLr signaling. These studies indicate that the ECD-TM and the TM-ICD are capable of modulating PRLr function. We also demonstrated an endogenous TM-ICD in T47D cells, suggesting that these findings are relevant to PRL-signaling pathways in breast cancer.
authors.affiliation: Department of Pathology, Northwestern University, Lurie 4-107, 303 East Superior Street, Chicago, Illinois 60611, USA.
authors.forename: Samantha L
authors.initials: SL
authors.lastname: Gadd
authors.forename: Charles V
authors.initials: CV
authors.lastname: Clevenger
mesh_terms: D000818:Animals; D016466:CHO Cells; D019556:COS Cells; D002522:Chlorocebus aethiops; D006224:Cricetinae; D019281:Dimerization; D006801:Humans; D008024:Ligands; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism; D010766:Phosphorylation; D011485:Protein Binding; D011489:Protein Denaturation; D020033:Protein Isoforms; D017434:Protein Structure, Tertiary; D011981:Receptors, Prolactin / Q000378:metabolism* / Q000502:physiology*; D015398:Signal Transduction; D014162:Transfection; D015003:Yeasts / Q000166:cytology
chemical_list: D008024:Ligands; D008565:Membrane Proteins; D010446:Peptide Fragments; D020033:Protein Isoforms; D011981:Receptors, Prolactin